Genetic background modulates outcome of therapeutic amyloid peptides in treatment of neuroinflammation.

Kraus A, Race B, Phillips K, Winkler C, Saturday G, Kurnellas M, Rothbard JB, Groveman BR, Steinman L, Caughey B